i2e Elevate
Connected Decisions: Accelerating Outcomes from Portfolio to Patient
Friday, April 24, 2026
Convene, 530 Fifth Avenue, New York
Elevate is an exclusive, invite-only executive forum of senior R&D and portfolio leaders in NYC in April 2026, hosted by i2e Consulting. Designed as a focused leadership forum rather than a typical conference, Elevate brings together a select group of decision-makers from across the pharma R&D landscape. The focus of the event will be on practical, real-world topics: resource allocation, AI in Strategic Portfolio Management, prioritization and delivery, clinical clarity and portfolio governance challenges specific to pharma R&D.
Who should attend?
Why should you attend?
See the full elevate 2025 experience
A brief highlight of key exchanges, insights, and interactive moments that made our leadership forum memorable.
See the full 2025 experienceSpeakers at Elevate 2026
Agenda
Welcome & opening remarks
i2e leadership team
Keynote
Elaine Ravasco-Valdellon
VP, Head of Portfolio Planning and Intelligence
Get a front-row perspective on how large, complex pharma organizations are rethinking portfolio planning and intelligence.
Dynamic AI in PM
Dr. Peter Green
VP, Data & Analytics, i2e Consulting
AI is impacting the portfolio decision intelligence layer across forecasting, scenario planning, resource optimization. This session examines which are generating real decision quality and which are generating noise.
Break 1
SPM Track
Where portfolio management gets real
Tim Rumbaugh
VP, Program Management at Edward Lifesciences
AI in portfolio management is often discussed at the level of potential — rarely at the level of practice. This session changes that, translating AI into specific, coherent steps that lead to measurable outcomes in day-to-day work.
Clinical Track
David Sunderhaft
COO, RCC
John Finn
Senior Director, I&I TA Lead, Data Monitoring and Management, Pfizer
Speed, cost, quality: The trade-offs in clinical operations are getting harder. This session examines where leading organizations are finding genuine efficiency without eroding the rigor that outcomes depend on.
SPM Track
Clinical Track
Where portfolio management gets real
Tim Rumbaugh
VP, Program Management at Edward Lifesciences
AI in portfolio management is often discussed at the level of potential — rarely at the level of practice. This session changes that, translating AI into specific, coherent steps that lead to measurable outcomes in day-to-day work.
David Sunderhaft
COO, RCC
John Finn
Senior Director, I&I TA Lead, Data Monitoring and Management, Pfizer
Speed, cost, quality: The trade-offs in clinical operations are getting harder. This session examines where leading organizations are finding genuine efficiency without eroding the rigor that outcomes depend on.
SPM Track
Dave Penndorf
Strategic Advisor, i2e Consulting
Many portfolio organizations are experimenting with AI, yet few initiatives affect real decision-making. This session challenges leaders to define sponsor-worthy use cases, confront data and governance constraints, and outline practical steps toward scalable portfolio impact.
Clinical Track
Jennifer Norwood
Principal, Aquivance Partners
Translating AI ambition into clinical and portfolio execution is harder than most roadmaps suggest. This session shares what that process looks like in practice - the progress, the friction, and the lessons.
SPM Track
Clinical Track
Dave Penndorf
Strategic Advisor, i2e Consulting
Many portfolio organizations are experimenting with AI, yet few initiatives affect real decision-making. This session challenges leaders to define sponsor-worthy use cases, confront data and governance constraints, and outline practical steps toward scalable portfolio impact.
Jennifer Norwood
Principal, Aquivance Partners
Translating AI ambition into clinical and portfolio execution is harder than most roadmaps suggest. This session shares what that process looks like in practice - the progress, the friction, and the lessons.
Mini roundtable + poster session
The most productive conversations in portfolio management rarely happen in formal sessions. This roundtable is built around specific, real-world problem statements - from resource planning under shifting priorities to cost forecasting inefficiencies and data noise - creating space for the kind of peer-level exchange that turns individual struggles into collective insights.
Lunch
SPM Track
Carlos Nunes
Strategic Advisor, i2e Consulting
Explore how algorithm-driven, adaptive planning models are enabling portfolio teams to respond to change in real time rather than catching up.
Clinical Track
Dr. Peter Green
VP, Data & Analytics, i2e Consulting
An integrated visibility architecture that brings disparate data sources together to enable faster, more confident decision-making at every level of the organization.
SPM Track
Clinical Track
Carlos Nunes
Strategic Advisor, i2e Consulting
Explore how algorithm-driven, adaptive planning models are enabling portfolio teams to respond to change in real time rather than catching up.
Dr. Peter Green
VP, Data & Analytics, i2e Consulting
An integrated visibility architecture that brings disparate data sources together to enable faster, more confident decision-making at every level of the organization.
Break 2
SPM Track
These sessions bring together leaders from across the SPM and Clinical Technology ecosystem for an honest conversation about how we may move to genuinely connected intelligence.
Clinical Track
These sessions bring together leaders from across the SPM and Clinical Technology ecosystem for an honest conversation about how we may move to genuinely connected intelligence.
SPM Track
Clinical Track
These sessions bring together leaders from across the SPM and Clinical Technology ecosystem for an honest conversation about how we may move to genuinely connected intelligence.
These sessions bring together leaders from across the SPM and Clinical Technology ecosystem for an honest conversation about how we may move to genuinely connected intelligence.
Customer panel: From insight to intervention: Where portfolio and clinical decisions break down
The distance between a portfolio insight and a meaningful intervention is shorter in theory than in practice. This panel with R&D leaders examines where and how decisions stall, where alignment fractures, and where the handoff between portfolio and clinical teams loses something critical.
Closing notes
i2e leadership team
Social Reception
Agenda is subject to change.
Limited spots available, RSVP today to reserve your spot.
Elevate is where pharma's most forward-thinking portfolio and clinical leaders come together.
One day, one room, and the kind of peer connections and practical insights that translate directly into smarter decisions and measurable impact back at your organization.
Can you afford to miss it?
Use our business justification document to build your business case for Elevate participation.
Reserve your seat at Elevate 2026 by registering early.
By submitting this form, you agree to our Terms of Use and Privacy Policy. Information provided by you may be collected and automatically stored in our database and may be used for sending you additional information about i2e Consulting and our services.
